• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别差异与高血压及其终生管理。

Sex Differences in Hypertension and Its Management Throughout Life.

机构信息

Division of Precision Medicine, Department of Medicine, NYU Langone Health, New York (W.-J.Y., R.A., A.L.S., C.M.F., M.E.G.).

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (P.S., B.O.).

出版信息

Hypertension. 2024 Nov;81(11):2263-2274. doi: 10.1161/HYPERTENSIONAHA.124.22980. Epub 2024 Sep 4.

DOI:10.1161/HYPERTENSIONAHA.124.22980
PMID:39229711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11483212/
Abstract

BACKGROUND

The prevalence of hypertension and uncontrolled hypertension may differ by age and sex.

METHODS

We included participants in the Atherosclerosis Risk in Communities study at seven study visits over 33 years (visit 1: 15 636 participants; mean age, 54 years; 55% women), estimating sex differences in prevalence of hypertension (systolic blood pressure ≥130 mm Hg; diastolic blood pressure ≥80 mm Hg; or self-reported antihypertension medication use) and uncontrolled hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg) using unadjusted and comorbidity-adjusted models.

RESULTS

The prevalence of hypertension increased with age from 40% (ages, 43-46 years) to 93% (ages, 91-94 years). Within hypertensive individuals, the prevalence of uncontrolled hypertension was higher in men (33%) than women (23%) at ages 43 to 46 years but became higher in women than men starting at ages 61 to 64, with 56% of women and 40% men having uncontrolled hypertension at ages 91 to 94. This sex difference was not explained by differences in coronary heart disease, diabetes, body mass index, estimated glomerular filtration rate, number of antihypertension medications, classes of medications, or adherence to medications. In both sexes, uncontrolled hypertension was associated with a higher risk for chronic kidney disease progression (hazard ratio, 1.5 [1.2-1.9]; =4.5×10), heart failure (hazard ratio, 1.6 [1.4-2.0]; =8.1×10), stroke (hazard ratio, 2.1 [1.6-2.8]; =1.8×10), and mortality (hazard ratio, 1.5 [1.3-1.6]; =6.2×10).

CONCLUSIONS

Sex differences in the prevalence of hypertension and uncontrolled hypertension vary by age, with the latter having implications for health throughout the life course.

摘要

背景

高血压和未控制高血压的患病率可能因年龄和性别而异。

方法

我们纳入了在 33 年的 7 次研究访问中参加动脉粥样硬化风险社区研究的参与者(第 1 次访问:15636 名参与者;平均年龄 54 岁;55%为女性),使用未经调整和合并症调整模型估计高血压(收缩压≥130mmHg;舒张压≥80mmHg;或自我报告使用抗高血压药物)和未控制高血压(收缩压≥140mmHg 或舒张压≥90mmHg)的患病率在性别之间的差异。

结果

高血压的患病率随着年龄的增长而增加,从 40%(年龄 43-46 岁)增加到 93%(年龄 91-94 岁)。在高血压患者中,男性(33%)在 43-46 岁时未控制高血压的患病率高于女性(23%),但从 61-64 岁开始,女性高于男性,91-94 岁时,56%的女性和 40%的男性患有未控制高血压。这种性别差异不能用冠心病、糖尿病、体重指数、估计肾小球滤过率、抗高血压药物的数量、药物类别或药物的依从性来解释。在两性中,未控制高血压与慢性肾脏病进展的风险增加相关(风险比,1.5[1.2-1.9];=4.5×10),心力衰竭(风险比,1.6[1.4-2.0];=8.1×10),中风(风险比,2.1[1.6-2.8];=1.8×10)和死亡率(风险比,1.5[1.3-1.6];=6.2×10)。

结论

高血压和未控制高血压的患病率在性别之间存在差异,且随年龄变化而变化,后者对整个生命周期的健康都有影响。

相似文献

1
Sex Differences in Hypertension and Its Management Throughout Life.性别差异与高血压及其终生管理。
Hypertension. 2024 Nov;81(11):2263-2274. doi: 10.1161/HYPERTENSIONAHA.124.22980. Epub 2024 Sep 4.
2
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
3
Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.2017 年 ACC/AHA 血压指南定义的孤立性舒张期高血压与心血管事件的发生风险相关。
JAMA. 2020 Jan 28;323(4):329-338. doi: 10.1001/jama.2019.21402.
4
Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.双重α和β受体阻滞剂对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2015 Aug 26;2015(8):CD007449. doi: 10.1002/14651858.CD007449.pub2.
5
Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial.高血压的公平护理:RICH LIFE 集群随机试验的血压和患者报告结局。
Circulation. 2024 Jul 16;150(3):230-242. doi: 10.1161/CIRCULATIONAHA.124.069622. Epub 2024 Jul 15.
6
Blood pressure targets for hypertension in people with chronic renal disease.高血压合并慢性肾脏病患者的血压目标。
Cochrane Database Syst Rev. 2024 Oct 15;10(10):CD008564. doi: 10.1002/14651858.CD008564.pub3.
7
Factors associated with progression of arterial stiffness in ischemic stroke survivors: the Norwegian Stroke in the Young Study.与缺血性脑卒中幸存者动脉僵硬度进展相关的因素:挪威青年卒中研究。
Blood Press. 2024 Dec;33(1):2298308. doi: 10.1080/08037051.2023.2298308. Epub 2024 Jan 7.
8
Antihypertensive withdrawal for the prevention of cognitive decline.停用抗高血压药物以预防认知功能减退。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD011971. doi: 10.1002/14651858.CD011971.pub2.
9
Prevalence of hypertension and high-normal blood pressure among young adults in Zimbabwe: findings from a large, cross-sectional population-based survey.津巴布韦年轻人中高血压和正常高值血压的患病率:一项大型、基于人群的横断面调查结果。
Lancet Child Adolesc Health. 2024 Feb;8(2):101-111. doi: 10.1016/S2352-4642(23)00287-0. Epub 2023 Dec 6.
10
Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networks.利用电子健康记录描述两大医疗系统网络中未控制的高血压患者的特征。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):497. doi: 10.1186/s12872-024-04161-x.

引用本文的文献

1
Data-driven identification of key predictors of uncontrolled hypertension: A cross-sectional study.基于数据驱动的未控制高血压关键预测因素识别:一项横断面研究。
PLoS One. 2025 Sep 4;20(9):e0331565. doi: 10.1371/journal.pone.0331565. eCollection 2025.
2
Cardiovascular contributions to dementia: Examining sex differences and female-specific factors.心血管因素与痴呆症的关系:探讨性别差异及女性特有因素。
Alzheimers Dement. 2025 Aug;21(8):e70610. doi: 10.1002/alz.70610.
3
Pharmacokinetic Variability of Amlodipine Serum Concentration and Effect on Blood Pressure in Patients Treated for Hypertension.氨氯地平血清浓度的药代动力学变异性及其对高血压治疗患者血压的影响。
Pharmacol Res Perspect. 2025 Aug;13(4):e70140. doi: 10.1002/prp2.70140.
4
Selenium and Coenzyme Q Supplementation and Sex Differences in Cardiovascular Mortality Results from a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly People Low in Selenium.补充硒和辅酶Q以及心血管疾病死亡率的性别差异:一项针对低硒老年人的前瞻性随机双盲安慰剂对照试验的结果
Antioxidants (Basel). 2025 Jun 5;14(6):685. doi: 10.3390/antiox14060685.
5
Sex difference in the association between metabolic syndrome and the risk of stroke: a systematic review and meta-analysis.代谢综合征与中风风险之间关联的性别差异:一项系统评价与荟萃分析。
Front Neurol. 2025 Jun 4;16:1527749. doi: 10.3389/fneur.2025.1527749. eCollection 2025.
6
The Interplay of Cancer and Hypertension: Rising Mortality and Widening Disparities Across the United States (1999-2023).癌症与高血压的相互作用:美国全国死亡率上升及差距扩大(1999 - 2023年)
Medicina (Kaunas). 2025 May 19;61(5):917. doi: 10.3390/medicina61050917.
7
The Particularities of Arterial Hypertension in Female Sex: From Pathophysiology to Therapeutic Management.女性动脉高血压的特殊性:从病理生理学到治疗管理
J Clin Med. 2025 May 1;14(9):3137. doi: 10.3390/jcm14093137.
8
Central nervous system mechanisms of salt-sensitive hypertension.盐敏感性高血压的中枢神经系统机制。
Physiol Rev. 2025 Oct 1;105(4):1989-2032. doi: 10.1152/physrev.00035.2024. Epub 2025 May 2.
9
Endothelial Activation and Stress Index Predicts All-Cause and Cardiovascular Mortality in Hypertensive Individuals: A Nationwide Study.内皮激活与应激指数可预测高血压患者的全因死亡率和心血管死亡率:一项全国性研究。
J Clin Hypertens (Greenwich). 2025 Apr;27(4):e70057. doi: 10.1111/jch.70057.
10
Sex differences in the association between preexisting comorbidities and COVID-19-related symptoms during the COVID-19 pandemic in the Dominican Republic.在多米尼加共和国新冠疫情期间,既往合并症与新冠相关症状之间关联的性别差异。
Front Public Health. 2025 Mar 18;13:1536627. doi: 10.3389/fpubh.2025.1536627. eCollection 2025.

本文引用的文献

1
Sex differences in blood pressure regulation and hypertension: renal, hemodynamic, and hormonal mechanisms.血压调节和高血压中的性别差异:肾脏、血液动力学和激素机制。
Physiol Rev. 2024 Jan 1;104(1):199-251. doi: 10.1152/physrev.00041.2022. Epub 2023 Jul 21.
2
Risk factors for falls among community-dwelling older adults: A systematic review and meta-analysis.社区居住老年人跌倒的危险因素:系统评价与荟萃分析。
Front Med (Lausanne). 2023 Jan 6;9:1019094. doi: 10.3389/fmed.2022.1019094. eCollection 2022.
3
Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care.高血压:初级保健中药物治疗、患病率和血压控制的性别差异。
J Hum Hypertens. 2023 Aug;37(8):662-670. doi: 10.1038/s41371-023-00801-5. Epub 2023 Jan 19.
4
Sex Differences in the Prevalence, Outcomes and Management of Hypertension.高血压的患病率、结局和管理中的性别差异。
Curr Hypertens Rep. 2022 Jun;24(6):185-192. doi: 10.1007/s11906-022-01183-8. Epub 2022 Mar 7.
5
Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials.药物性体位性低血压:随机对照试验的系统评价和荟萃分析
PLoS Med. 2021 Nov 9;18(11):e1003821. doi: 10.1371/journal.pmed.1003821. eCollection 2021 Nov.
6
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association.药物依从性与血压控制:美国心脏协会的科学声明。
Hypertension. 2022 Jan;79(1):e1-e14. doi: 10.1161/HYP.0000000000000203. Epub 2021 Oct 7.
7
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
8
Age and sex disparities in hypertension control: The multi-ethnic study of atherosclerosis (MESA).高血压控制方面的年龄和性别差异:动脉粥样硬化多民族研究(MESA)。
Am J Prev Cardiol. 2021 Aug 8;8:100230. doi: 10.1016/j.ajpc.2021.100230. eCollection 2021 Dec.
9
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.全球高血压流行病学、健康负担及有效干预措施
Nat Rev Cardiol. 2021 Nov;18(11):785-802. doi: 10.1038/s41569-021-00559-8. Epub 2021 May 28.
10
Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications.药物相关性直立性低血压:超越抗高血压药物。
Drugs Aging. 2020 Oct;37(10):725-738. doi: 10.1007/s40266-020-00796-5.